Aptus Capital Advisors, LLC Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Aptus Capital Advisors, LLC

  • $12.7 Billion
  • Q3 2025

A detailed history of Aptus Capital Advisors, LLC transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 528 shares of PPH stock, worth $52,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
528
Previous 524 0.76%
Holding current value
$52,198
Previous $46,000 2.17%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$82.58 - $90.36 $330 - $361
4 Added 0.76%
528 $47,000
Q2 2025

Aug 11, 2025
BUY
$80.28 - $91.78 $240 - $275
3 Added 0.58%
524 $46,000
Q1 2025

May 13, 2025
SELL
$85.24 - $94.86 $852 - $948
-10 Reduced 1.88%
521 $47,000
Q4 2024

Feb 14, 2025
SELL
$86.03 - $94.92 $43,015 - $47,460
-500 Reduced 48.5%
531 $45,000
Q1 2024

May 15, 2024
BUY
$82.63 - $90.89 $85,191 - $93,707
1,031 New
1,031 $93,000

Others Institutions Holding PPH

# of Institutions
142
Shares Held
7.98M
Call Options Held
39.7K
Put Options Held
446K
View Full List

About VANECK ETF TR VANECK PHARMACEU

PPH Quotes by TradingView
  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email